Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Blue Bird, Lowers Price Target to $50

Author: Benzinga Newsdesk | May 08, 2025 12:31pm
Barclays analyst Adam Seiden maintains Blue Bird (NASDAQ:BLBD) with a Overweight and lowers the price target from $54 to $50.

Posted In: BLBD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist